We provide a digital platform called MacuTest to predict your risk of progressing to the advanced stages of Age-related Macular Degeneration (AMD), a blinding and incurable disease. According to your risk, we provide you with personalised lifestyle recommendations to help you preserve your vision. Our technology was developed by the Eye Risk consortium in the framework of the European program Horizon 2020. www.eyerisk.eu
| Website | http://www.macutest.com |
| Employees | 9 (1 on RocketReach) |
| Address | 406, Boulevard Jean-Jacques Bosc, Bègles, Nouvelle-Aquitaine 33130, FR |
| Industry | Hospitals and Health Care |
| Keywords | Macular Degeneration Screening, Age Related Macular Degeneration, Ocular Health, Eye Health Technology, Vision Loss Prevention, Vision Care, Digital Health Platform, Prevent Blindness, Teleophthalmology |
| Competitors | Celerion, Covance, Quotient Sciences, Labcorp, Parexel, Charles River Laboratories, CROMSOURCE, Medpace, PharPoint Research, Inc., Syneos Health +39 more (view full list) |
Looking for a particular RetiNov employee's phone or email?
Soufiane Ajana is the CEO of RetiNov.
1 people are employed at RetiNov.
RetiNov is based in Bègles, Nouvelle-Aquitaine.